Suchergebnisse
Unser Katalog
Artikel & mehr
Suchmaske
Suchergebnisse einschränken oder erweitern
Aktive Suchfilter
- Entferne Filter: Thema: rc254-282
- Entferne Filter: Verlag: frontiers media s.a.
- Entferne Filter: Thema: immune checkpoint inhibitors
- Entferne Filter: Thema: chemotherapy
- Entferne Filter: Art der Quelle: eBooks
- Entferne Filter: Art der Quelle: Videos
- Entferne Filter: Art der Quelle: Academic Journals
Weniger Treffer
Art der Quelle
Thema
- meta-analysis 6 Treffer
- immunotherapy 5 Treffer
- gastric cancer 3 Treffer
- malignant melanoma 2 Treffer
- network meta-analysis 2 Treffer
-
45 weitere Werte:
- non-small cell lung cancer 2 Treffer
- non-small-cell lung cancer 2 Treffer
- pd-1/pd-l1 2 Treffer
- radiotherapy 2 Treffer
- systematic review 2 Treffer
- triple-negative breast cancer 2 Treffer
- angiogenesis inhibitors 1 Treffer
- antiangiogenic 1 Treffer
- anti-angiogenic therapy 1 Treffer
- bevacizumab 1 Treffer
- biliary tract cancer 1 Treffer
- braf 1 Treffer
- brain metastases 1 Treffer
- cancer treatment 1 Treffer
- combination therapy 1 Treffer
- combinations 1 Treffer
- cost-effectiveness 1 Treffer
- esophageal squamous cell cancer 1 Treffer
- extensive-stage small-cell lung cancer 1 Treffer
- first-line therapy 1 Treffer
- first-line treatment 1 Treffer
- gemcitabine 1 Treffer
- immune-monitoring 1 Treffer
- lmics 1 Treffer
- lung cancer 1 Treffer
- lung immune prognostic index 1 Treffer
- nab-paclitaxel 1 Treffer
- neutrophil-to-lymphocyte ratio 1 Treffer
- nomogram 1 Treffer
- non-small cell lung cancer (nsclc) 1 Treffer
- non-small lung cancer 1 Treffer
- nsclc 1 Treffer
- pancreatic cancer 1 Treffer
- pd-1 1 Treffer
- progression-free survival (pfs) 1 Treffer
- randomized controlled trial 1 Treffer
- randomized trials 1 Treffer
- salvage therapy 1 Treffer
- sclc 1 Treffer
- small cell lung cancer 1 Treffer
- small-cell lung cancer 1 Treffer
- solid cancer 1 Treffer
- survival 1 Treffer
- systemic therapy 1 Treffer
- targeted therapy 1 Treffer
Sprache
Inhaltsanbieter
24 Treffer
-
In: Frontiers in Oncology, Jg. 14 (2024-04-01)Online academicJournalZugriff:
-
Addition of PD-1/PD-L1 inhibitors to chemotherapy for triple-negative breast cancer: a meta-analysisIn: Frontiers in Oncology, Jg. 14 (2024-02-01)Online academicJournalZugriff:
-
In: Frontiers in Oncology, Jg. 13 (2024)Online academicJournalZugriff:
-
In: Frontiers in Oncology, Jg. 13 (2023-12-01)Online academicJournalZugriff:
-
In: Frontiers in Oncology, Jg. 13 (2023-10-01)Online academicJournalZugriff:
-
In: Frontiers in Oncology, Jg. 13 (2023-08-01)Online academicJournalZugriff:
-
In: Frontiers in Oncology, Jg. 13 (2023-04-01)Online academicJournalZugriff:
-
In: Frontiers in Oncology, Jg. 13 (2023-03-01)Online academicJournalZugriff:
-
In: Frontiers in Oncology, Jg. 12 (2022-12-01)Online academicJournalZugriff:
-
In: Frontiers in Oncology, Jg. 12 (2022-12-01)Online academicJournalZugriff:
-
In: Frontiers in Oncology, Jg. 12 (2022-11-01)Online academicJournalZugriff:
-
In: Frontiers in Oncology, Jg. 12 (2022-11-01)Online academicJournalZugriff:
-
In: Frontiers in Oncology, Jg. 12 (2022-11-01)Online academicJournalZugriff:
-
In: Frontiers in Oncology, Jg. 12 (2022-09-01)Online academicJournalZugriff:
-
In: Frontiers in Oncology, Jg. 12 (2022-08-01)Online academicJournalZugriff:
-
In: Frontiers in Oncology, Jg. 11 (2022)Online academicJournalZugriff:
-
In: Frontiers in Oncology, Jg. 11 (2021-12-01)Online academicJournalZugriff:
-
In: Frontiers in Oncology, Jg. 11 (2021-10-01)Online academicJournalZugriff:
-
In: Frontiers in Oncology, Jg. 11 (2021-09-01)Online academicJournalZugriff:
-
In: Frontiers in Oncology, Jg. 11 (2021-09-01)Online academicJournalZugriff: